o-chlorophentermine
Small moleculeexperimental
Clortermine hydrochloride (Voranil) is a non-amphetamine anorexigenic agent. Voranil, a sympathomimetic amine, is indicated for short-term adjunctive treatment of exogenous obesity. Its long duration of action permits once-a-day dosage. In a large number of patients studied, Voranil was found to be superior to placebo in weight reduction. Insomnia, dry mouth, palpitations and tachycardia have been reported in a small percentage of patients taking the drug. Voranil was originally developed by Ciba Pharmaceuticals Corporation and transferred to USV Pharmaceuticals Corporation in December 1971, as a result of a product exchange agreement. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Indications
Approved for
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)(N)Cc1ccccc1Cl- Mol. weight
- 183.68 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1697833 ↗
- NCATS4FA88HM3IX ↗
- ChEMBLCHEMBL2107635 ↗
Also known as
- chlortermine
- clortermine
- clortermine
- clortermine hcl
- clortermine hydrochloride
- clortermine hydrochloride
- clortermine hydrochloride
- clortermine hydrochloride
- clortermine hydrochloride
- o-chlorophentermine